- Vinay Prasad, an oncologist, appointed as the director of FDA's Center for Biologics Evaluation and Research.
- Controversial views on COVID-19 mandates and pharmaceutical industry.
- Criticized CDC's inclusion of COVID-19 in childhood immunization schedule. 4. Raised questions about future drug regulations and accelerated approvals.
- Marty Makary, FDA's commissioner, supports Prasad's appointment.
- Prasad's appointment impacts biotech stocks.
- Holds medical degree from the University of Chicago.
- Previous stints at National Cancer Institute and National Institutes of Health.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
